Wednesday, July 23, 2008

Retinal Implants

Within the past few decades, procedures to replace and repair damaged or destroyed retinas have become more and more common, including several different options. Epiretinal Implants sit on top of the retina, directly stimulating ganglia using signals sent from the external camera and power sent from an external transmitter. Being as there are several different options it would only be expected for one to be recommended over another. That being said, I would recommend epiretinal implants, which sit on top of the retina, over subretinal implants, which sit under the retina.

While both types are showing promise in clinical trials I do find some faults with subretinal implants. For example, with some types of subretinal implant they are not able to have strong enough external power sources. Epiretinal implants sit on top of the retina and are therefore more easily accessible from power sources. However, since there are both still in the clinical trial stage it is possible that subretinal implants can be later seen as the more sensible choice.

 References: http://en.wikipedia.org/wiki/Retinal_implant

Artificial Silicon Retina

Marissa Reitsma

The Artificial Silicon Retina (ASR) is a new retinal implant designed to help people with end stage retinitis pigmentosa improve their vision. The new retinal prosthesis, manufactured by Optobionics, is only 2mm. in diameter and only 25 microns (1/1000 inch) in thickness. After surgery, the ASR requires no externally worn devices. In addition, the implant does not require any wires or batteries. Instead, the ASR is powered solely by incident light. The ASR chip uses about 5,000 microscopic solar cells that work to convert light into electrical impulses. Since the ASR makes use of the natural optic nerve, brain surgery and wiring is not required to restore vision. On the other hand, the retinal prosthesis can only be used if the optic nerve is still fully functional. 
The ASR implant is still in clinical trial phase, and it has seen variable success. Most of the patients who recieved the implant reported improvement in color vision, the ability to read letters, and an expansion of their visual field. Also, many patients experienced a positive affect on their walking abilities since they were not constantly bumping into unseen objects. The advantages of the ASR are that it requires no external visual device, no brain surgery, and no battery.
Random new study: Spinach protein may be able to serve as an artificial retina in a similar way to the ASR. The protein gives off a small electrical voltage after capturing incoming photons. 

http://medgadget.com/archives/2005/02/optobionics_art.html
http://www.sciencedaily.com/releases/2005/04/050429100652.htm
http://www.rachnaindia.com/fzone/fz/asr.htm

Cortical Implants

Cortical Implants

Cortical implants are a great form of visual prosthesis. The way they work is that they collect images through an external camera, which then relays these images to the brain where they are processed. However, cortical implants are different from other types of visual aids in that they do not require any sort of implant in one’s brain; such is the case with the sub retinal implants. Sub retinal implants carry a certain risk of infection or rejection as there is a foreign object being inserted into the eye of the patient. The main idea behind cortical implants is that they bypass the eye all together since the signals are sent from the camera device (worn on the head) to an electrode array which is connected to the visual cortex ( a part of the brain). The main hope for cortical implants is that they may one day become wireless. In this case, the user would have fewer “things” to carry with them seeing as they have to carry a battery pack on their waste at all times as well as super cool head gear which allows them to see. Wireless CI units would allow the user to look more “normal” since the only thing about them that would be different is the fact that they would be wearing sunglasses all the time. The chip that would relay signals and images to the brain would be implanted inside the tissue of the brain itself; this implant is known as a penetrating implant. At this point, scientists have yet to refine this process of penetrating implants, but this discovery is just on the horizon now. And when they have perfected the system of penetrating implants and sending signals to the visual cortex, cortical implants will become a much more popular form of visual prosthesis.

http://www.jwen.com/rp/articles/cortical.html

http://science.jrank.org/pages/543/Artificial-Vision-Cortical-implants.html

Just an Implant

Alexis Gorin

Farah Laiwalla

Engineering Biomedical Systems (BI920-3B)

Wednesday, July 23, 2008

Unless most of the eye is damaged, a subretinal implant, compared to a cortial or epiretinal implant, is the most minimal implant to work with. Unlike the cortial implant, there is not a machinery to worry about, and there are no wires hooked up to the brain. Unlike the epiretinal implant, there are no external pieces and it uses the person's own eye movements, allowing a more natural look to the user and easier use of the technology. The main part of a subretinal implant is simply a stimulation chip, allowing easy use without all the extra macrotechnology used by both of the other types of retinal implants.

A subretinal implant also allows working neurons in the eye to continue processing electrical signals, since they are still intact. Considering that the implant is placed closer to the inner retinal neurons as well, it can also stimulate the eye effectively with a decreased number of currents (Javaheri et al). In the subretinal space, it is also easier to position and fix the implant using non-mechanical devices, leading to less trauma on the eye due to the implantation of the subretinal implant.

Javaheri et al, Michael. "Retinal Prostheses for the Blind." Annals Academy of Medicine Vol. 35 No. 3Mar 2006 141-143. 23 Jul 2008 http://www.annals.edu.sg/pdf/35VolNo3200604/V35N3p137.pdf.

"Optoelectronic implants to treat visual diseases." OpticsReport. 12 June 2007. Optics Report. 23 Jul 2008 http://www.opticsreport.com/content/article.php?article_id=1007.

Zrenner , Eberhart . "Will Retinal Implants Restore Vision? ." Science Vol. 295. no. 55578 Feb 2002 1022 - 1025. 23 Jul 2008 http://www.sciencemag.org/cgi/content/full/295/5557/1022.

Subretinal Implants

Research that led to the subretinal implant began in 1995. The device has now reached the stage of clinical testing after 10 years of research. Measuring 3 x 3 x 0.1 mm, the chip contains 1,500 photodiodes, amplifiers and electrodes. The external energy supply is a power line implanted subdermally. The implant depends on the light reaching the retina. This becomes a stimulus to the photodiodes of the implant. Because the implant is placed directly on the retina, it can communicate through the electrodes to the nerves in the eye.

Eberhart Zrenner, MD, presented the results of the first trials. After 30 days, the seven patients with implants did not experience any complications during or after the procedure. Some visual perception was restored in six out of the seven patients. Despite the lengthy implantation process (5 hours), improvements were recorded. Recognition of vertical and horizontal orientation pixels showed improvement along with differentiation of angles and movement. A wide range of brightness was perceived. The brightness and size of the dots viewed correlated with the voltage of the stimulation.

Even though results differed among the patients, all the patients were happy with the outcome. Just to see light again was a great experience. The next trials will include the effects of a long term implantation of 3 – 6 months. For now, the researchers are working on ways to improve the spatial resolution and the energy supply with the stimulation. The first trial producing positive feedback is encouraging. However, the subretinal implant is far from perfect but shows signs of potential vision for the blind.

OSN SuperSite:
http://www.osnsupersite.com/view.asp?rID=25565

New Tattoo Ink Erases Any Regrets

Since we've talked about polymer microspheres, I thought you guys might be interested in this new "biomedical" application of that technology. This product was developed in my lab. -Dan

PROVIDENCE — Having someone's name permanently etched into your flesh is considered by some to be the ultimate testament to a relationship. But wouldn't it be great to make that commitment without really making it ... forever?
A new dye due to hit tattoo parlors this fall will provide an exit strategy of sorts for people who have thought about getting a tattoo, then wondered if they might someday have regrets.
The permanent but removable ink is made by storing dye in microscopic capsules that will stay in the skin for good. But if that butterfly tattoo on the small of your back starts looking lame, it can be zapped away with a single laser treatment that is simpler and less painful than the barrage of treatments now needed.
While the idea might intrigue some — for example, the 36% of Americans ages 18 to 29 who get tattoos, according to a 2006 study by the Journal of American Academy of Dermatology— some enthusiasts say getting inked without the lifetime commitment wouldn't be appealing. Those in the industry are also skeptical, especially since the company making the dye says it will cost considerably more than a regular tattoo.
"I don't know anyone who would pay more for a tattoo where their thought is, 'Maybe one day I'm going to remove this,'" said Jerry Lorito, vice president of the tattoo removal company Tat2BeGone in Costa Mesa, Calif.
The idea was developed in the late 1990s by Rox Anderson, a dermatology professor at Harvard University who founded the New York-based company Freedom-2 in 1999 to bring the product to market.
In 2004, Anderson approached Edith Mathiowitz, a professor of medical science and engineering at Brown University. Mathiowitz specializes in microcapsulating medicines, DNA, hormones and insulin in plastic polymers, which control the time and rate of the drug's release in the body. Some molecules are designed to break open when exposed to heat, ultraviolet light or ultrasound.
Using the same technology, Mathiowitz trapped dye pigments in microscopic beads coated with a safe, biodegradable plastic.
It's possible to remove regular tattoos with lasers, but it can cost thousands of dollars and usually requires between seven to 15 treatments.
With each conventional laser treatment, the dye is broken down into fragments until they are small enough to be carried away by the bloodstream, usually into the lymph nodes. But the Freedom-2 ink particles held in the tiny beads are already small enough. In just one laser treatment, the polymers combust, and the fragments are released and naturally expelled from the body, Mathiowitz said.
She hopes to eventually design molecules that will dissolve over time for a long-term temporary tattoo that would not require any laser treatment.
Mathiowitz doesn't have a tattoo and said that as a scientist, she never thought she'd be working with them. But she said she is happy to help improve an ancient art form.
"This will make tattoos so much safer. None of the toxins from the ink will be able to leak out" and linger in the dermis, as occurs with conventional tattoos, Mathiowitz said.
Freedom-2 boasts it could save a painful and costly removal process for those who have their heart broken or make a spring break mistake.
"Regret is a strong word, but there are people who are parents or are in a job where they do not want their tattoo to show," said Martin Schmieg, president of Freedom-2. "There are times that your life circle changes things, and the form of self-expression you were proud of in your past just doesn't match now."
Schmieg is the only person to use the ink so far. He tattooed his bicep with the company's red logo, then removed it four months later. Photos show the color has disappeared and only a shadow of it looms. Schmieg said it has since faded.
For Elke O'Connor, 39, of Los Angeles, having a decade-old tribal print removed from her throat is costing her at least $1,000, about a dozen laser treatments and pain she described as "excruciating." "It's the worst pain I've ever had in my life," said O'Connor, who had her first treatment last week. "It's like razor blades cutting you."
Despite the pain, she said she still would have declined if she had the option for removable ink back then. "When someone's going into something like getting a tattoo, it's usually something they want forever," she said.
Lorito said the biggest obstacle the company faces is marketing the product to tattoo salons, where he said temporary tattoos, made from henna or vegetable dye that last weeks and sometimes months, are frowned upon.
"When an artist tattoos somebody, in their mind, they want their work on that body for the rest of that person's life," he said.
At Bambu Tattoo Art Studio in Providence, tattoo artist George Dietz said he's skeptical about whether the ink will last, and said he probably won't use it when it's available this fall.
"If people don't want something permanent," he said, "they shouldn't get a tattoo."

Problems with the Medtronic Fidelis Defibrillator Leads

Most implantable defibrillator units contain two leads, thus the preferred type of lead is the small diameter high-voltage lead, which is easier to insert and possibly remove. However, HV lead model, the Medtronic Sprint Fidelis has been pulled due off the market since the leads could fracture. For patients with the device, which is implanted near the shoulder and connected to the body with leads, according to Medtronic, removing the leads can cause more complications than the fracture itself would cause. Medtronic believes that out of 1000 patients with the affected leads, 9 of them will have leads fracture, with half of them given more than two days’ notice and the other half less than two days notice or no notice at all. A study at the Minneapolis heart institute had six of 583 patients experience lead failure. The fractures would cause unnecessary shocks or cause the unit not to function at all. Two options, plus removal, are available to patients. One option is to monitor the device for signs of fracture. Medtronic is developing new software for the pacemakers that would give three days notice before the unit fails. Another option is to surgically implant a replacement lead while capping the Fidelis lead. However, according to a study, monitoring did not detect nor prevent the failure of the device in 2/3 of the patients. In Minneapolis, none of the patients had complications from neither lead extrication nor removal.
Sources:
Linda M. Kallinen, Robert G. Hauser, Ken W. Lee, Adrian K. Almquist, William T. Katsiyiannis, Chuen Y. Tang, Daniel P. Melby, Charles C. Gornick, Failure of impedance monitoring to prevent adverse clinical events caused by fracture of a recalled high-voltage implantable cardioverter-defibrillator lead, Heart RhythmVolume 5, Issue 6, , June 2008, Pages 775-779.
(http://www.sciencedirect.com/science/article/B7GW9-4S01WMP-D/1/6a9881ae45ab62e7574e77bc9ed83b22)
Keywords: Implantable cardioverter-defibrillator; Lead; Complications; Follow-up

Robert G. Hauser, Linda M. Kallinen, Adrian K. Almquist, Charles C. Gornick, William T. Katsiyiannis, Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead, Heart RhythmVolume 4, Issue 7, , July 2007, Pages 892-896.
(http://www.sciencedirect.com/science/article/B7GW9-4NFXDKJ-3/1/a5783e4201e37af697bd3654c5626c86)
Keywords: Implantable cardioverter-defibrillator; Lead; Complications; Failure

http://www.fda.gov/consumer/updates/medtronic101507.html

http://wwwp.medtronic.com/Newsroom/NewsReleaseDetails.do?itemId=1192213397218?=en_US

http://www.medtronic.com/fidelis/physician-letter-may-2008.html

Dalkon Shield

The Dalkon Shield is a "contraceptive intrauterine device" or IUD that lead to numerous injuries in women as well as a number of expensive lawsuits. This device was claimed to prevent pregnancy as well as infections. It was coined as a "technological breakthrough" and had as many as 2.8 million women using it at one time in the US. However none of these women were informed of the risks of this faulty device.
The most important thing the inventors and investors at the Dalkon Corporation failed to do was to test their product sufficiently. Only one insignificant study was put out but later was found to be false because of the investigator's conflict of interest. It was later proven that he had invested in the company and was given a percentage of the profits. This investigator failed to report to the users that the device could carry bacteria to the sterile environment of the uterus. The longer the device stayed in the body, the more bacteria was introduced. Another problem involved the tailstring of the device that underwent hydrolysis in the body. This lead to the disintegration of the outer shealth and even more passage ways for bacteria to enter. And finally, another part of the design became embedded in a layer of the uterus speeding up the process of infectious diseases since this tissue is extremely susceptible to infections. Because of the faulty design, bacteria caused thousands of women numerous infections and diseases ranging from pelvic inflammatory disease (PID) to infertility.
Over 300,000 lawsuits were filed against the Dalkon Corporation and eventually lead to FDA's requirement of testing medical devices through the Medical Device Amendments.



http://en.wikipedia.org/wiki/Dalkon_Shield

Medtronic Fidelis Pacemaker

Medtronic Fidelis Pacemakers
In October of 2007 Medtronic a leading manufacturer of biomedical devices was forced to recall one of their products. Recently the company decided to switch leads on their pacemaker. The Quattro lead is much thicker and more difficult to thread through into the heart. The new Fidelis lead is much thinner and were thought to help out surgeons during the procedure. The fidelis leads were later discovered to fracture, though. This could either cause the signal to not get to the heart or it would corrupt data that the lead collects. Corrupted data would cause the pacemaker to make erratic beats. If misfires of this sort happened to rapidly it would induce heart attacks. This problem had already attributed to five deaths by December of that year only 2 months later. The company itself came out that the failure rate was 2.3% of patients who have already had the pacemaker for three months. This would, on a bigger scale, affect 5,000 out of the total 235,000 who have received these implants.
The company did assume responsibility for this problem and began to immediately recall them. They promised to pay for some of the cost of the lead replacement surgery. This compensation was fairly insufficient, for they only contributed $800 out of the total $12,500 cost of the surgery. Besides that the people who actually needed the surgery didn’t know they needed until it was too late. No one knew who was in that 5,000. So often times, against their physician’s recommendation, wanted to receive the replacement surgery just to be sure they would be okay.
Afterwards, the FDA met with some other regulatory organizations to try and come up with a better system for making sure that the new biomedical devices that were being put on the market were tested. This could surly be considered one of the largest biomedical device disasters, solely due to the large numbers of potential subjects and the large number of uncertainty.


Gibb, Gordan. “Medtronic fidelis lead: a nightmare for patients.” Lawyers and Settlements.com. 2007. Online Legal Marketing Ltd. 22 July 2008. .

Drug Eluting Stents

When drug eluting stents were first invented, they were so well recieved that they "doubled the world market for stents to $5 Billion annually" (angioplasty.org). Designed with a drug coating to prevent renstenosis, or the closing of the arteries, they were thought to be the perfect solution for patient following angioplastey; Not only did the metal structure prevent most cases of renostenosis directly following angioplasty, but the drug prevented most cases of renostenosis following the implantation of a normal metal stent.
However, recent patterns in patients who use drug eluting stents has suggested they might be linked to problematic conditions. But because they were developed in the 90s, they are a fairly recent invention and have not been on the market long enough to be conclusively linked to any fatal event. Despite this, there is some evidence that they might be linked to an increased chance of thrombosis (clotting which causes blockage of a blood vessel), particularly "Late Stent Thrombosis," which, as its name implies, is thrombosis that occurs a year or two after the stent is implanted.
There are also other problems. Allergic inflamatory reactions, which increase the chance of thrombosis, are worried to be linked to use of Drug eluding stents. Though there is very little evidence to support this according to angioplasty.org, there are a large number of people who feel it could be related to the polymer used in creating the stent. One proposal to confront this problem is an allergy test in which polymers are tested on a patient before putting the stent in the body. Anti-platelet medication must also be taken to prevent platelets from forming on the stent, but due to the drugs which slow down cell growth on the stent, anit-platelet medication must be taken for a longer period of time than with regular metal stents and deal with all the risks that come from use of such medication (most notable of which is hemoraging).

http://www.ptca.org/des.html
http://www.aetna.com/cpb/medical/data/600_699/0621.html
http://heartdisease.about.com/od/angioplastystents/a/DESproblems.htm
http://www.ashcraftandgerel.com/stent_lawsuit.html

The Dalkon Shield: The Great Scam

The Intrauterine Device (IUD) is the most widely used contraceptive for woman in the world. The story is not quite the same in the United States. The IUD in this country has a sort of stigma around it, and it comes from the catastrophic results of popular IUD known as the Dalkon Shield sold in the U.S. beginning in 1971. The results of this faulty medical device were taken up in a 2.5 billion dollar class-action lawsuit.

The doctors and businessman involved with the production and sale of this device all knew that the severe risks associated with their product, but decided that the profit gained from the 2.8 million women who at one point in time were using the IUD had a greater weight in their decisions. Years later it was discovered that only one small study was held for the IUD, and that it was held to the ends of preventing pregnancy, not the possible complications of pelvis infection that could have followed. Also, further investigation revealed that the researchers involved in this experiment "cheated" their way to positive results by telling the women who volunteered to use spermicide along with the IUD.

The complications that later rose from the use of the IUDs came from the original design of the Shield. The wicking properties of the IUD and its place in the female anatomy. The wet cavity of the vagina leaves room for bacteria, whereas the uterus must be kept sterile the entire time. The properties of the Shield provided a sort of gateway for bacteria to enter the uterus. In this usually sterile environment, this condition, called sepsis, leads to pelvic inflammatory disease and could become fatal.

While the company greatly promoted and supported the product, the results experienced by most women could not be ignored, nor could the litigation that soon followed. The story of this IUD is tragic, as it forever cast a dark shadow on the contraceptive technology that followed, and it revealed what some people were greedy enough to do at any costs.

1. "Dalkon Shield." Wikipedia. .

Hey, we only use 10% of our Brain

The statement that suggests we only use 10% of our brains is completely false. There are a few possible reasons about how this saying came about, one being my own and the other being more factual, but either way it is false. I'll begin with my own explanation for its origins; someone was so aggravated at not being able to solve a problem that they needed an explanation for why they were so dumb. Unfortunately, while I was investigating this myth no other published article seemed to agree with my reasoning. One article suggested that it may have been on account of misunderstanding great scientist, such as Albert Einstein, who all suggested that we were not using all of our possible intellect as human beings. Unfortunately, the people who do only use 10% of their brain took these quotes far too literally and managed to drag the rest of us down with them : ). There is one more explanation which, besides my own, I find the most likely. It suggests that people may justify the 10% theory because only 1 out of every 10 nerve cells in the brain are essential at any one point in time. This still however does not justify the 10% theory, so before anyone goes to use this saying for motivation or for an explanation for getting a "D" on a test, make sure the person your talking to still believes that it's true.

Kyle

The Medtronic Fidelis Pacemaker

The Fidelis lead was originally introduced as an improvement to the Quattro lead, which is thicker. Thinner leads are easier to thread for the surgeon, and were thought to be an improvement all around.However, it was found that the advantage to the Fidelis lead—its thin design—was contributing to hairline fractures that would impede the electrical impulses being delivered to the heart. The problem also proved to be a double-edged sword, given the dual role of the lead as a conduit for sending vital information from the heart to the Medtronic device. A fracture in the lead would garble the data, potentially causing the pacemaker or defibrillator to behave in an erratic fashion.Just as a pacemaker or defibrillation device fails in the delivery of life-saving shocks to the heart when needed, a device that delivers unnecessary shocks can pose an equal risk to the heart. At least one of the five deaths blamed on the fractured Fidelis lead occurred after a Medtronic device misfired so rapidly, it caused a heart attack.This has become an issue for thousands of Fidelis lead patients. In announcing the recall October 15th, Medtronic reported a failure rate of 2.3 per cent within 30 months of implantation. That translates to 5,000 patients out of the 235,000 who have received the Fidelis lead since they were first introduced.That's 5,000 individuals who might expect, statistically, that a fracture is on the horizon.But what of the other 230,000 patients? Statistically they should be fine. However, that's cold comfort. There are no lots drawn, or names pulled out of a hat, or patients rostered into either this group, or that. It leaves 230,000 patients wondering, constantly, if they will be one of the unlucky 5,000.
http://www.personalinjurylawcal.com/medtronic-sprint-pacemaker.html
Eric Shine
Engineering Biomedical Systems
July 23, 2008

The brain doesn't grow new cells


There is a common belief in our society that our brains do not regenerate neurons. It has always been thought that we are born with all of the brain cells we re ever going to have (all 100 billion or so). Also that a human brain cannot regenerate brain cells in adulthood and that memory works by the growth of axon and dendrite connections. This idea of neurogenisis has been supported by years of research by neuroscientist. According to a study done by Princeton neuroscientists they used chemical tracers in an adult macaque monkey brain to track brain activity. The researchers found a rim-like layer of stem cells that covered over the ventricles of the brain. Theses stem cells produced as steady stream of neurons, which floated to the cortex of the brain, specifically the frontal lobe and parietal lobe. As an extension to this research, these neuroscientists want to be able to control the placement of these neurons to help treat diseases like Alzheimer’s and Parkinson’s. But, to be able to do this research, neurogenisis needs to be confirmed in humans.
More and more research is being done in this evolving field of neurogenisis. Some scientist even believe that neurogenisis occurs more efficiently under certain environmental conditions, more nutrients for cell growth. Even though the full effects of neurogenisis has not been understood, scientist are making ground breaking discoveries to understand more about the brain.


References:
http://en.wikipedia.org/wiki/Neurogenesis
http://www.sciencedaily.com/releases/2006/12/061223092924.htm
http://www.brainlightning.com/regen.html

The Brain DOES grow new Cells

Myth Heard About Brain

The Brain does not grow new Cells

Dennis Xuan


There was once a myth that your Brain just didn’t make new cells during its lifetime. The theory was that although almost all human tissues could repair themselves with stem cells the brain could only compensate for damage by making new connections between surviving neurons. The theory that the Brain does not spawn new cells has been debunked by scientists studying the hippocampus. They found that the hippocampus, which is an important part of the brain pertaining to memory and learning, can actually produce new nerve cells. The relative number produced is low compared to the total number of cells in the brain but this discovery does offer a chance to help patients with neurological disorders.

The findings that the brain can produce more cells can help patients with diseases such as Parkinson’s and Alzheimer’s. If doctors and medical professionals can stimulate growth of new cells in the brain some of these neurological disorders can be somewhat alleviated if not totally fixed. So the myth that the brain doesn’t grow new cells has been totally thrown out the window.

http://www.dsrf.co.uk/Reading_material/New_braincells/newbrain1.htm

http://biopsychiatry.com/newbraincell/index.html

Brain Myth: Logic and Creativity

Jason Sedlak

Brain Myths: Logic and Creativity

http://www.rense.com/general2/rb.htm


A common myth about the human brain is that the left side of brain completely deals with all things logical

and mathematical while the left brain dabbles and controls the more creative side of man. In a brain-scanning study conducted by London's Institute of Neurology, a subject looked at a large letter made of smaller, different letters: a large S made of small F’s, for example. The results showed the left side of the brain fired when the subject was focusing on details (the F’s), and the right fired when the subject was thinking about the bigger picture (the S). In another study with patients whom had their brain separated into the two hemispheres as an epilepsy treatment, the subject was shown a cake on a plate. The left part of the brain would connect the image to a fork and knife while the right saw the cake in spatial terms, and associated it with a broad-brimmed hat. The conclusion made by Hellige (One of he lead researchers) was that the distinction between the brain sides was not what they processed, but how they processed information. A smart brain became one that simultaneously grasped both the foreground and the background of the moment.” 

Hm. So whats the story behind Silicone Breast implants?


Silicone breast implants has been the most controversial procedure in the history of implants. The first breast implants were available on the market in 1895. Many women that had the breast implants started getting connective tissue disorders after receiving the implants. Starting in the late 1980’s and the 1990’s there was a large recall of silicone breast implants. Many women had to go to get them removed. The problem with this was that many health insurance companies didn’t cover the cost of the removal even though the cost of getting implants was covered by the health insurance companies.

The main cause of the recall of silicone breast implants was because of connective tissue disorders. Later studies showed that connective tissue disorders had nothing to do with the implant. In a study of 87,000 participants between 1979 and 1990 there was not a link between silicone breast implants and connective tissues disorder. Another possible reason for this problem was that in the 1970’s surgeons started making the lining of the breast implant thinner to give it a more realistic feel. The thinner lining made it easier for the implants to rupture.

In November of 2006 the FDA approved silicone breast implants to be used again after a 14 year ban. Today’s silicone breast implants are made differently than they were made in the 1960’s and 70’s. There are still many risks with getting implants like there are in other surgeries.



http://www.aboardcertifiedplasticsurgeonresource.com/breast_augmentation/augmentation_studies.

http://en.wikipedia.org/wiki/Breast_implant#Silicone_gel_implants

http://www.webmd.com/news/20061117/silicone-breast-implants-get-fda-nod
http://www.justbreastimplants.com/implants/silicone.htm


Percentage of Brain Used

There are many myths about the brain that may or may not be true. One myth is that humans only use about 10% of our brain. This myth was coined by Albert Einstein and since then has been scientifically proven to be false. His logic was that only one out of every 10 nerve cells are being used, thus we only use 10% of our brain. There is scientifical evidence which proves this to not be true: even if neurons are not firing action potentials, they could still be recieving signals from other neurons. The fact is if you look at a cognitive brain map, every part of the brain is used. There are many different parts of the brain which aid other parts of the brain in successfully equipping a human being. Also, there is no point in having that much space in the brain if we only use 10% of it. For an example, consider a patient who experiences a traumatic blow to the head. When they go to a doctor, the doctor tells them they have brain damage all around the brain. They don't say, "Oh, you only have brain damage in this part of your brain, but good thing that's not the 10% of your brain that you actually use." The whole brain is used in everyday life. Every part of the brain works together to form a working machine. Some say that this myth still continues due to popular media continuing to advocate this false myth.

http://www.time-etc.com/2007/06/ten-myths-about-brain.html

http://faculty.washington.edu/chudler/tenper.html

Medtronic Fidelis Pacemaker

Medtronic's Fidelis pacemaker was different from other pacemakers most notably because of its lead. The lead on this pacemaker was thinner than usual, which was intentional in the pacemaker's design, due to the greater ease surgeons would have routing and connecting it to the heart. However, what made the pacemaker easier to set up in patients introduced a gigantic problem for the pacemaker's operation.

The thinner lead was much more prone to fracturing. This, obviously, would disrupt electrical impulses being sent to a malfunctioning heart. It would also scramble signals from the heart back to the pacemaker, which is just as dangerous; one paient with a Fidelis pacemaker died because the pacemaker, receiving jumbled data through a fractured lead, misfired very rapidly based on the incorrect data, causing a heart attack. The pacemaker was recalled on October 15th, 2007; Medtronic announced upon recalling their device that there had been a 2.3% failure rate in paients within the first 30 months receiving the device. Though this may seem like a small percentage, there are around 235,000 people with the Fidelis pacemaker. This means that roughly 5,000 patients can expect to have fractures in the leads of their pacemakers.

Replacing leads is no easy or inexpensive task: many complications can arise from removing leads from hearts, and the operation costs $12,500. Medtronic now offers replacement leads for free, and up to $800 towards the cost of the operation, but only upon reccomendation on lead removal by a doctor; not all people are in good enough condition for such an operation. And even with $800 towards the operation, patients deemed suitable to replacement may still be barely able or unable to afford the $11,700.